Invitris is a biotech company that develops protein-based drugs.
Invitris's investors include Y Combinator, EIC Accelerator, Mergus Ventures, Vehiculum Capital.
Invitris is headquartered in Garching Bei Múnchen, Germany.
Invitris is a biotech company that develops protein-based drugs.
Invitris is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Invitris — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/invitris. Accessed July 21, 2026.
VCBacked. (2025). Invitris — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/invitris
{{cite web |title=Invitris — Funding & Investors |url=https://www.vcbacked.co/company/invitris |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated